Do analysts prefer COG or INHC?

Cambridge Cognition currently has a consensus price target of GBX 56, suggesting a potential upside of 51.35%. Given Cambridge Cognition's stronger consensus rating and higher possible upside, equities analysts plainly believe Cambridge Cognition is more favorable than Induction Healthcare Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cambridge Cognition 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Induction Healthcare Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer FDBK or COG?

Cambridge Cognition has a consensus target price of GBX 56, suggesting a potential upside of 51.35%. Given Cambridge Cognition's stronger consensus rating and higher possible upside, analysts plainly believe Cambridge Cognition is more favorable than Feedback. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Feedback 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Cambridge Cognition 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts rate COG or IQAI?

Cambridge Cognition presently has a consensus price target of GBX 56, indicating a potential upside of 51.35%. Given Cambridge Cognition's stronger consensus rating and higher probable upside, research analysts clearly believe Cambridge Cognition is more favorable than IQ-AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cambridge Cognition 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 IQ-AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation & earnings, COG or IQAI?

IQ-AI has lower revenue, but higher earnings than Cambridge Cognition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cambridge Cognition £9.40M 1.83 -£1.58M -£3.90 N/A IQ-AI £538.19K 3.30 N/A N/A N/A

Is COG or IQAI more profitable?

Cambridge Cognition has a net margin of -17.82% compared to IQ-AI's net margin of -77.52%. Cambridge Cognition's return on equity of -62.89% beat IQ-AI's return on equity. Company Net Margins Return on Equity Return on Assets Cambridge Cognition -17.82% -62.89% -0.30% IQ-AI -77.52% -140.75% -22.03%

Cambridge Cognition (COG) Competitors

GBX 37 0.00 (0.00%)

As of 06/5/2026 12:00 PM Eastern

Compare

COG vs. KOO, INHC, RENX, FDBK, and IQAI

Should you buy Cambridge Cognition stock or one of its competitors? MarketBeat compares Cambridge Cognition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cambridge Cognition include Kooth (KOO), Induction Healthcare Group (INHC), Renalytix (RENX), Feedback (FDBK), and IQ-AI (IQAI). These companies are all part of the "health information services" industry.

How does Cambridge Cognition compare to Kooth?

Kooth (LON:KOO) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kooth	£63.29M	0.92	£4.00M	£7.00	22.86
Cambridge Cognition	£9.40M	1.83	-£1.58M	-£3.90	N/A

Kooth has a beta of 1.238, indicating that its stock price is 24% more volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market.

Kooth has a net margin of 4.12% compared to Cambridge Cognition's net margin of -17.82%. Kooth's return on equity of 8.84% beat Cambridge Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kooth	4.12%	8.84%	10.12%
Cambridge Cognition	-17.82%	-62.89%	-0.30%

Kooth presently has a consensus target price of GBX 330, suggesting a potential upside of 106.25%. Cambridge Cognition has a consensus target price of GBX 56, suggesting a potential upside of 51.35%. Given Kooth's higher possible upside, equities research analysts clearly believe Kooth is more favorable than Cambridge Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kooth	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Kooth's average media sentiment score of 0.00 equaled Cambridge Cognition'saverage media sentiment score.

Company	Overall Sentiment
Kooth	Neutral
Cambridge Cognition	Neutral

21.7% of Kooth shares are held by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are held by institutional investors. 30.6% of Kooth shares are held by insiders. Comparatively, 3.4% of Cambridge Cognition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Kooth beats Cambridge Cognition on 12 of the 13 factors compared between the two stocks.

How does Cambridge Cognition compare to Induction Healthcare Group?

Cambridge Cognition (LON:COG) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

In the previous week, Cambridge Cognition's average media sentiment score of 0.00 equaled Induction Healthcare Group'saverage media sentiment score.

Company	Overall Sentiment
Cambridge Cognition	Neutral
Induction Healthcare Group	Neutral

Cambridge Cognition has a net margin of -17.82% compared to Induction Healthcare Group's net margin of -23.86%. Induction Healthcare Group's return on equity of -14.58% beat Cambridge Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cambridge Cognition	-17.82%	-62.89%	-0.30%
Induction Healthcare Group	-23.86%	-14.58%	-7.32%

Cambridge Cognition has higher earnings, but lower revenue than Induction Healthcare Group. Cambridge Cognition is trading at a lower price-to-earnings ratio than Induction Healthcare Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cambridge Cognition	£9.40M	1.83	-£1.58M	-£3.90	N/A
Induction Healthcare Group	£12.57M	0.72	-£5.12M	-£5.54	N/A

15.9% of Cambridge Cognition shares are owned by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are owned by institutional investors. 3.4% of Cambridge Cognition shares are owned by company insiders. Comparatively, 54.6% of Induction Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cambridge Cognition currently has a consensus price target of GBX 56, suggesting a potential upside of 51.35%. Given Cambridge Cognition's stronger consensus rating and higher possible upside, equities analysts plainly believe Cambridge Cognition is more favorable than Induction Healthcare Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Induction Healthcare Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Cambridge Cognition has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market. Comparatively, Induction Healthcare Group has a beta of -0.41, suggesting that its share price is 141% less volatile than the broader market.

Summary

Cambridge Cognition beats Induction Healthcare Group on 9 of the 14 factors compared between the two stocks.

How does Cambridge Cognition compare to Renalytix?

Cambridge Cognition (LON:COG) and Renalytix (LON:RENX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

In the previous week, Cambridge Cognition's average media sentiment score of 0.00 equaled Renalytix'saverage media sentiment score.

Company	Overall Sentiment
Cambridge Cognition	Neutral
Renalytix	Neutral

15.9% of Cambridge Cognition shares are held by institutional investors. Comparatively, 14.0% of Renalytix shares are held by institutional investors. 3.4% of Cambridge Cognition shares are held by company insiders. Comparatively, 5.1% of Renalytix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cambridge Cognition has higher revenue and earnings than Renalytix. Cambridge Cognition is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cambridge Cognition	£9.40M	1.83	-£1.58M	-£3.90	N/A
Renalytix	£3.30M	2.62	-£109.93M	-£4.00	N/A

Cambridge Cognition has a net margin of -17.82% compared to Renalytix's net margin of -680.00%. Renalytix's return on equity of 274.67% beat Cambridge Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cambridge Cognition	-17.82%	-62.89%	-0.30%
Renalytix	-680.00%	274.67%	-93.54%

Cambridge Cognition has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market. Comparatively, Renalytix has a beta of 1.974, suggesting that its share price is 97% more volatile than the broader market.

Cambridge Cognition currently has a consensus target price of GBX 56, suggesting a potential upside of 51.35%. Given Cambridge Cognition's stronger consensus rating and higher probable upside, equities research analysts plainly believe Cambridge Cognition is more favorable than Renalytix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Renalytix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Cambridge Cognition beats Renalytix on 9 of the 14 factors compared between the two stocks.

How does Cambridge Cognition compare to Feedback?

Feedback (LON:FDBK) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings.

In the previous week, Feedback's average media sentiment score of 0.00 equaled Cambridge Cognition'saverage media sentiment score.

Company	Overall Sentiment
Feedback	Neutral
Cambridge Cognition	Neutral

Cambridge Cognition has a consensus target price of GBX 56, suggesting a potential upside of 51.35%. Given Cambridge Cognition's stronger consensus rating and higher possible upside, analysts plainly believe Cambridge Cognition is more favorable than Feedback.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Feedback	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Cambridge Cognition has higher revenue and earnings than Feedback. Cambridge Cognition is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Feedback	£849.62K	3.76	-£10.84M	-£15.74	N/A
Cambridge Cognition	£9.40M	1.83	-£1.58M	-£3.90	N/A

Cambridge Cognition has a net margin of -17.82% compared to Feedback's net margin of -845.25%. Cambridge Cognition's return on equity of -62.89% beat Feedback's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Feedback	-845.25%	-135.17%	-22.99%
Cambridge Cognition	-17.82%	-62.89%	-0.30%

Feedback has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market.

35.7% of Feedback shares are owned by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are owned by institutional investors. 8.0% of Feedback shares are owned by company insiders. Comparatively, 3.4% of Cambridge Cognition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Cambridge Cognition beats Feedback on 9 of the 14 factors compared between the two stocks.

How does Cambridge Cognition compare to IQ-AI?

Cambridge Cognition (LON:COG) and IQ-AI (LON:IQAI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Cambridge Cognition has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, IQ-AI has a beta of 2.25, indicating that its share price is 125% more volatile than the broader market.

In the previous week, Cambridge Cognition's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score.

Company	Overall Sentiment
Cambridge Cognition	Neutral
IQ-AI	Neutral

15.9% of Cambridge Cognition shares are held by institutional investors. 3.4% of Cambridge Cognition shares are held by company insiders. Comparatively, 66.0% of IQ-AI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cambridge Cognition presently has a consensus price target of GBX 56, indicating a potential upside of 51.35%. Given Cambridge Cognition's stronger consensus rating and higher probable upside, research analysts clearly believe Cambridge Cognition is more favorable than IQ-AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
IQ-AI	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Cambridge Cognition has a net margin of -17.82% compared to IQ-AI's net margin of -77.52%. Cambridge Cognition's return on equity of -62.89% beat IQ-AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cambridge Cognition	-17.82%	-62.89%	-0.30%
IQ-AI	-77.52%	-140.75%	-22.03%

IQ-AI has lower revenue, but higher earnings than Cambridge Cognition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cambridge Cognition	£9.40M	1.83	-£1.58M	-£3.90	N/A
IQ-AI	£538.19K	3.30	N/A	N/A	N/A

Summary

Cambridge Cognition beats IQ-AI on 9 of the 12 factors compared between the two stocks.

Get Cambridge Cognition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COG vs. The Competition

Export

Metric	Cambridge Cognition	Health Information Services Industry	Medical Sector	LON Exchange
Market Cap	£17.23M	£320.50M	£6.46B	£2.79B
Dividend Yield	N/A	5.59%	2.68%	6.12%
P/E Ratio	-9.49	230.75	23.82	365.23
Price / Sales	1.83	132.32	577.54	87,121.98
Price / Cash	4.31	47.14	42.42	27.85
Price / Book	5.09	5.46	9.73	7.68
Net Income	-£1.58M	-£22.78M	£3.57B	£5.89B
7 Day Performance	N/A	-0.93%	-1.26%	-0.50%
1 Month Performance	8.82%	1.22%	0.82%	2.10%
1 Year Performance	-5.13%	-10.71%	24.09%	72.87%

Cambridge Cognition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COG Cambridge Cognition	1.3639 of 5 stars	GBX 37 flat	GBX 56 +51.4%	+2.4%	£17.23M	£9.40M	N/A	80	Gap Up
KOO Kooth	2.3123 of 5 stars	GBX 175 +2.6%	GBX 330 +88.6%	-11.5%	£63.47M	£63.29M	25.00	478
INHC Induction Healthcare Group	N/A	GBX 9.75 flat	N/A	+4.2%	£9.00M	£12.57M	N/A	74
RENX Renalytix	N/A	GBX 1.60 -11.1%	N/A	-73.0%	£6.99M	£3.30M	N/A	102	Gap Down
FDBK Feedback	N/A	GBX 8 -1.2%	N/A	-49.8%	£3.51M	£849.62K	N/A	24

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:COG) was last updated on 6/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cambridge Cognition (COG) Competitors

COG vs. KOO, INHC, RENX, FDBK, and IQAI

How does Cambridge Cognition compare to Kooth?

Summary

How does Cambridge Cognition compare to Induction Healthcare Group?

Summary

How does Cambridge Cognition compare to Renalytix?

Summary

How does Cambridge Cognition compare to Feedback?

Summary

How does Cambridge Cognition compare to IQ-AI?

Summary

Media Sentiment Over Time

COG vs. The Competition

Cambridge Cognition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cambridge Cognition (COG) Competitors

COG vs. KOO, INHC, RENX, FDBK, and IQAI

How does Cambridge Cognition compare to Kooth?

Which has preferable earnings and valuation, KOO or COG?

Which has more risk and volatility, KOO or COG?

Is KOO or COG more profitable?

Do analysts prefer KOO or COG?

Does the media refer more to KOO or COG?

Do institutionals & insiders hold more shares of KOO or COG?

Summary

How does Cambridge Cognition compare to Induction Healthcare Group?

Does the media refer more to COG or INHC?

Is COG or INHC more profitable?

Which has preferable earnings and valuation, COG or INHC?

Do insiders & institutionals hold more shares of COG or INHC?

Do analysts prefer COG or INHC?

Which has more risk and volatility, COG or INHC?

Summary

How does Cambridge Cognition compare to Renalytix?

Does the media favor COG or RENX?

Do insiders & institutionals hold more shares of COG or RENX?

Which has better earnings and valuation, COG or RENX?

Is COG or RENX more profitable?

Which has more volatility and risk, COG or RENX?

Do analysts prefer COG or RENX?

Summary

How does Cambridge Cognition compare to Feedback?

Does the media favor FDBK or COG?

Do analysts prefer FDBK or COG?

Which has stronger earnings and valuation, FDBK or COG?

Is FDBK or COG more profitable?

Which has more volatility & risk, FDBK or COG?

Do insiders and institutionals hold more shares of FDBK or COG?

Summary

How does Cambridge Cognition compare to IQ-AI?

Which has more volatility and risk, COG or IQAI?

Does the media refer more to COG or IQAI?

Do institutionals and insiders believe in COG or IQAI?

Do analysts rate COG or IQAI?

Is COG or IQAI more profitable?

Which has better valuation & earnings, COG or IQAI?

Summary

Media Sentiment Over Time

COG vs. The Competition

Cambridge Cognition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools